Agios Pharmaceuticals reported $1.89B in Cash and Equivalent for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 455.51M 215.44M
Agios Pharmaceuticals AGIO:US $ 1888.02M 1760.59M
Alexion Pharmaceuticals ALXN:US $ 3429.6M 465.1M
Alnylam Pharmaceuticals ALNY:US $ 379.54M 117.04M
Amgen AMGN:US $ 6112M 154M
Arrowhead Research ARWR:US $ 372.38M 232.46M
Astellas Pharma 4503:JP Y 326128M 19614M
AstraZeneca AZN:LN 7636M 196M
Bayer BAYN:GR € 5550M 1359M
Biogen BIIB:US $ 1742M 524.5M
Biomarin Pharmaceutical BMRN:US $ 667.31M 18.16M
Bluebird Bio BLUE:US $ 439.71M 122.01M
Bristol Myers Squibb BMY:US $ 10982M 3564M
Daiichi Sankyo 4568:JP Y 380547M 139527M
Eli Lilly And LLY:US $ 3002.4M 654.7M
Epizyme EPZM:US $ 73.71M 94.5M
Gilead Sciences GILD:US $ 6245M 248M
GlaxoSmithKline GSK:LN 4757M 1535M
Immunogen IMGN:US $ 283.12M 10.74M
Mirati Therapeutics MRTX:US $ 294.89M 570.28M
Moderna Inc MRNA:US 5.44B 2.82B
Nektar Therapeutics NKTR:US $ 150.16M 48.79M
Novartis NVS:US $ 5117M 1316M
Novartis NOVN:VX SF 3801M 5857M
Puma Biotechnology PBYI:US $ 95.65M 10.36M
Regeneron Pharmaceuticals REGN:US $ 1437.9M 755.8M
Sarepta Therapeutics SRPT:US $ 1481.84M 20.81M
Seattle Genetics SGEN:US $ 373.71M 184.71M
Vertex Pharmaceuticals VRTX:US $ 6923.97M 935.78M
YTE INCY:US $ 1962.39M 449.38M